These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12629075)

  • 1. A case report in favor of a multistep adrenocortical tumorigenesis.
    Bernard MH; Sidhu S; Berger N; Peix JL; Marsh DJ; Robinson BG; Gaston V; Le Bouc Y; Gicquel C
    J Clin Endocrinol Metab; 2003 Mar; 88(3):998-1001. PubMed ID: 12629075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
    Gicquel C; Raffin-Sanson ML; Gaston V; Bertagna X; Plouin PF; Schlumberger M; Louvel A; Luton JP; Le Bouc Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2559-65. PubMed ID: 9253334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
    Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
    Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
    J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for malignancy in adrenocortical tumors.
    Gicquel C; Le Bouc Y
    Horm Res; 1997; 47(4-6):269-72. PubMed ID: 9167963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
    Bourcigaux N; Gaston V; Logié A; Bertagna X; Le Bouc Y; Gicquel C
    J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular pathogenesis of childhood adrenocortical tumors.
    Almeida MQ; Latronico AC
    Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative genomic hybridization analysis of adrenocortical tumors.
    Sidhu S; Marsh DJ; Theodosopoulos G; Philips J; Bambach CP; Campbell P; Magarey CJ; Russell CF; Schulte KM; Röher HD; Delbridge L; Robinson BG
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3467-74. PubMed ID: 12107267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors.
    Tissier F; Louvel A; Grabar S; Hagnéré AM; Bertherat J; Vacher-Lavenu MC; Dousset B; Chapuis Y; Bertagna X; Gicquel C
    Eur J Endocrinol; 2004 Jun; 150(6):809-17. PubMed ID: 15191351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis.
    Leboulleux S; Gaston V; Boulle N; Le Bouc Y; Gicquel C
    Eur J Endocrinol; 2001 Feb; 144(2):163-8. PubMed ID: 11182753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
    Fottner Ch; Hoeflich A; Wolf E; Weber MM
    Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.
    Kjellman M; Kallioniemi OP; Karhu R; Höög A; Farnebo LO; Auer G; Larsson C; Bäckdahl M
    Cancer Res; 1996 Sep; 56(18):4219-23. PubMed ID: 8797595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.
    Zhao J; Speel EJ; Muletta-Feurer S; Rütimann K; Saremaslani P; Roth J; Heitz PU; Komminoth P
    Am J Pathol; 1999 Oct; 155(4):1039-45. PubMed ID: 10514385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor system on adrenocortical tumorigenesis.
    Ribeiro TC; Latronico AC
    Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genomic hybridization analysis of adrenocortical tumors of childhood.
    Figueiredo BC; Stratakis CA; Sandrini R; DeLacerda L; Pianovsky MA; Giatzakis C; Young HM; Haddad BR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1116-21. PubMed ID: 10084604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the p16 tumor suppressor gene in adrenocortical tumors.
    Pilon C; Pistorello M; Moscon A; Altavilla G; Pagotto U; Boscaro M; Fallo F
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2776-9. PubMed ID: 10443678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.